Answers are grounded in this paper and cite their sources.
This guideline supports improved antipsychotic prescribing for females with first-episode psychosis, highlighting important patient outcomes.
This is the first CPG addressing antipsychotic choice for females with FEP. By prioritizing critically important patient outcomes and lived experience, the guideline supports safer, sex-sensitive prescribing for females that may improve treatment acceptability, adherence, and equity in psychosis care.
No takes yet. Share an insight, caveat, or question.
Hynes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: